Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-06 Sale |
2022-06-07 7:39 pm |
Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer |
82 | $0.71 | $58 | 4,183 (Direct) |
View |
2022-06-06 Sale |
2022-06-07 7:37 pm |
Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer |
442 | $0.71 | $314 | 13,163 (Direct) |
View |
2022-03-31 Sale |
2022-04-01 9:09 pm |
Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer |
8,116 | $0.2101 | $1,705 | 146,425 (Direct) |
View |
2022-03-31 Sale |
2022-04-01 9:08 pm |
Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs |
4,006 | $0.2101 | $842 | 56,331 (Direct) |
View |
2022-03-31 Sale |
2022-04-01 9:07 pm |
Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer |
23,633 | $0.2101 | $4,965 | 460,709 (Direct) |
View |
2021-11-23 Sale |
2021-11-24 5:53 pm |
Zosano Pharma Corp | ZSAN | GREATHOUSE KENNETH Director |
10,000 | $0.6018 | $6,018 | 43,500 (Direct) |
View |
2021-06-04 Sale |
2021-06-07 6:44 pm |
Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer |
13,158 | $0.805 | $10,592 | 365,592 (Direct) |
View |
2021-06-04 Sale |
2021-06-07 6:43 pm |
Zosano Pharma Corp | ZSAN | Lewis Hayley See Remarks |
1,709 | $0.805 | $1,376 | 49,779 (Direct) |
View |
2021-06-04 Sale |
2021-06-07 6:42 pm |
Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs |
1,709 | $0.805 | $1,376 | 50,337 (Direct) |
View |
2021-06-04 Sale |
2021-06-07 6:41 pm |
Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer |
1,709 | $0.805 | $1,376 | 98,291 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-12-07 Option Award |
2021-12-09 6:35 pm |
N/A 2031-12-06 |
Zosano Pharma Corp | ZSAN | Yang Elaine Director |
90,000 | $0 | 90,000 (Direct) |
View |
2021-10-15 Option Award |
2021-10-19 9:36 pm |
N/A 2031-10-14 |
Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs |
30,000 | $0 | 80,337 (Direct) |
View |
2021-10-15 Option Award |
2021-10-19 9:35 pm |
N/A 2031-10-14 |
Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer |
168,750 | $0 | 267,041 (Direct) |
View |
2021-10-15 Option Award |
2021-10-19 9:34 pm |
N/A 2031-10-14 |
Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer |
356,250 | $0 | 721,842 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 9:36 pm |
N/A 2031-06-09 |
Zosano Pharma Corp | ZSAN | Grais Linda Director |
45,000 | $0 | 52,500 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 8:38 pm |
N/A 2031-06-09 |
Zosano Pharma Corp | ZSAN | ELMS STEVE Director |
45,000 | $0 | 2,770,726 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 8:36 pm |
N/A 2031-06-09 |
Zosano Pharma Corp | ZSAN | GREATHOUSE KENNETH Director |
45,000 | $0 | 83,500 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 8:35 pm |
N/A 2021-06-09 |
Zosano Pharma Corp | ZSAN | XANTHOPOULOS KLEANTHIS G Director |
45,000 | $0 | 53,596 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 8:31 pm |
N/A 2031-06-09 |
Zosano Pharma Corp | ZSAN | Hagan Joseph P Director |
45,000 | $0 | 52,500 (Direct) |
View |
2021-05-24 Option Award |
2021-05-25 6:29 pm |
N/A 2031-05-23 |
Zosano Pharma Corp | ZSAN | McGee Kathy M. Director |
90,000 | $0 | 90,000 (Direct) |
View |
2021-05-17 Option Award |
2021-05-18 7:45 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | GREATHOUSE KENNETH Director |
21,000 | $0.7291 | 38,500 (Direct) |
View |
2021-03-30 Option Award |
2021-04-01 9:33 pm |
N/A 2031-03-29 |
Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer |
697,500 | $0 | 843,750 (Direct) |
View |
2021-03-30 Option Award |
2021-04-01 9:33 pm |
N/A 2031-03-29 |
Zosano Pharma Corp | ZSAN | Lewis Hayley See Remarks |
97,500 | $0 | 116,488 (Direct) |
View |
2021-03-30 Option Award |
2021-04-01 9:31 pm |
N/A 2031-03-29 |
Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs |
97,500 | $0 | 117,046 (Direct) |
View |
2021-03-30 Option Award |
2021-04-01 9:30 pm |
N/A 2031-03-29 |
Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer |
243,750 | $0 | 262,500 (Direct) |
View |
2021-03-18 Option Award |
2021-03-19 6:13 pm |
N/A 2031-03-17 |
Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer |
450,000 | $0 | 450,000 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:57 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | GREATHOUSE KENNETH Director |
7,500 | $0 | 17,500 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:56 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | Grais Linda S Director |
7,500 | $0 | 7,500 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:55 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer |
146,250 | $0 | 146,250 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:55 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | XANTHOPOULOS KLEANTHIS G Director |
7,500 | $0 | 8,596 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:54 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | Hagan Joseph P Director |
7,500 | $0 | 7,500 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:52 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | WALKER JOHN PETER Director |
7,500 | $0 | 116,511 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:52 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | Lewis Hayley See Remarks |
18,750 | $0 | 18,988 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:50 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs |
18,750 | $0 | 19,546 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:48 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer |
18,750 | $0 | 18,750 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:47 pm |
N/A N/A |
Zosano Pharma Corp | ZSAN | ELMS STEVE Director |
7,500 | $0 | 2,725,766 (Direct) |
View |
2020-06-03 Option Award |
2020-06-05 6:43 pm |
N/A 2030-06-02 |
Zosano Pharma Corp | ZSAN | WALKER JOHN PETER Director |
15,000 | $0 | 124,011 (Direct) |
View |
2020-06-03 Option Award |
2020-06-05 5:11 pm |
N/A 2030-06-02 |
Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer |
292,500 | $0 | 292,500 (Direct) |
View |